老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Reviva Pharmaceuticals Holdings, Inc.

0.3600
-0.0250-6.49%
盘后：0.37400.0140+3.89%16:59 EDT
成交量：213.78万
成交额：80.09万
市值：2,448.13万
市盈率：-0.47
高：0.3955
开：0.3955
低：0.3600
收：0.3850
数据加载中...
总览公司新闻资讯公告
2021/05/07

重要事件披露

8-K - Current report
2021/05/07

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/19

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/04/15

重要事件披露

8-K - Current report
2021/03/24

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/22

重要事件披露

8-K - Current report
2021/03/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/04

重要事件披露

8-K - Current report
2021/01/20

重要事件披露

8-K/A [Amend] - Current report
2021/01/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/01/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/29

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/21

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/18

重要事件披露

8-K - Current report
更多